+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
CD40 Ligand - Pipeline Review, H2 2019 - Product Thumbnail Image

CD40 Ligand - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 74 Pages
  • Global
From
From
Italian Distribution Market - Healthcare Logistics Contracts - Product Thumbnail Image

Italian Distribution Market - Healthcare Logistics Contracts

  • Report
  • September 2021
  • 28 Pages
  • Italy
From
From
From
From
From
From
From
Environmental Trends in Healthcare - Thematic Intelligence - Product Thumbnail Image

Environmental Trends in Healthcare - Thematic Intelligence

  • Report
  • January 2023
  • 57 Pages
  • Global
From
From
From
Biogen - Product Thumbnail Image

Biogen

  • Company Profile
  • July 2020
  • 41 Pages
From
From
Biogen, Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

Biogen, Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • April 2025
  • 47 Pages
From
Loading Indicator